Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,032,194
-$292,309 QoQ
Shares Held
16,658
-7.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#746
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. AMGN ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
This page
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,032,194 | 16,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,324,503 | 17,975 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,482,769 | 16,751 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,183,332 | 14,824 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,225,284 | 15,133 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,225,864 | 13,564 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,864,097 | 7,152 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,581,868 | 8,013 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,501,162 | 8,005 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,120,742 | 7,459 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,367,524 | 8,220 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,991,780 | 7,411 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,342,776 | 6,048 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,767,917 | 7,313 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,720,817 | 6,552 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,377,870 | 6,113 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,439,119 | 5,915 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,382,968 | 5,719 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,156,345 | 5,140 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,396,685 | 6,568 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,374,018 | 5,637 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,357,507 | 5,456 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,089,360 | 4,738 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,215,647 | 4,783 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,426,953 | 6,050 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,841,165 | 9,082 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||